148 related articles for article (PubMed ID: 27900532)
1. MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women.
Bedene A; Mencej Bedrač S; Ješe L; Marc J; Vrtačnik P; Preželj J; Kocjan T; Kranjc T; Ostanek B
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):519-526. PubMed ID: 27900532
[TBL] [Abstract][Full Text] [Related]
2. miRNAs in bone tissue correlate to bone mineral density and circulating miRNAs are gender independent in osteoporotic patients.
Kelch S; Balmayor ER; Seeliger C; Vester H; Kirschke JS; van Griensven M
Sci Rep; 2017 Nov; 7(1):15861. PubMed ID: 29158518
[TBL] [Abstract][Full Text] [Related]
3. Circulating Hsa-miR499a-5p as markers in dysmobility syndrome patients: a new index for diagnosing dysmobility syndrome based on osteoporosis and predicting fracture risk.
Geng Z; Wang P; Yang G; Li Y; Zhao Y
Postgrad Med J; 2024 Apr; 100(1183):297-304. PubMed ID: 38263934
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA signature associated with skeletal muscle wasting in post-menopausal osteoporotic women.
Faraldi M; Sansoni V; Vitale J; Perego S; Gomarasca M; Verdelli C; Messina C; Sconfienza LM; Banfi G; Corbetta S; Lombardi G
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):690-701. PubMed ID: 38272849
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs and endothelial cell migration rate are associated with metabolic syndrome and fitness level in postmenopausal African American women.
Sapp RM; Shill DD; Dash C; Hicks JC; Adams-Campbell LL; Hagberg JM
Physiol Rep; 2019 Jul; 7(14):e14173. PubMed ID: 31347282
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as potential biopredictors for premenopausal osteoporosis: a biochemical and molecular study.
Al-Rawaf HA; Gabr SA; Iqbal A; Alghadir AH
BMC Womens Health; 2023 Sep; 23(1):481. PubMed ID: 37689658
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.
Lote H; Mousoullou F; Vlachogiannis G; Lampis A; Satchwell L; Peckitt C; Fong C; Begum R; Kidd S; Cromarty S; Gordon A; Fribbens C; Rao S; Starling N; Chau I; Cunningham D; Valeri N
Front Oncol; 2023; 13():1258365. PubMed ID: 38094609
[TBL] [Abstract][Full Text] [Related]
8. Featured Article: Transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosis.
Maasalu K; Laius O; Zhytnik L; Kõks S; Prans E; Reimann E; Märtson A
Exp Biol Med (Maywood); 2017 Jan; 242(2):203-213. PubMed ID: 27856519
[TBL] [Abstract][Full Text] [Related]
9. Eupatilin ameliorates postmenopausal osteoporosis via elevating microRNA-211-5p and repressing Janus kinase 2/Signal transducer and activator of transcription 3 pathway.
Hong L; Yang C
Mol Cell Biochem; 2023 Oct; ():. PubMed ID: 37823974
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients.
Meerson A; Najjar A; Saad E; Sbeit W; Barhoum M; Assy N
Noncoding RNA; 2019 Apr; 5(2):. PubMed ID: 30959814
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.
Cammarata G; Scalia S; Colomba P; Zizzo C; Pisani A; Riccio E; Montalbano M; Alessandro R; Giordano A; Duro G
Oncotarget; 2018 Jun; 9(44):27333-27345. PubMed ID: 29937989
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated sprints training on fracture risk-associated miRNA.
Sansoni V; Perego S; Vernillo G; Barbuti A; Merati G; La Torre A; Banfi G; Lombardi G
Oncotarget; 2018 Apr; 9(26):18029-18040. PubMed ID: 29719588
[TBL] [Abstract][Full Text] [Related]
13. Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.
Kangas R; Törmäkangas T; Fey V; Pursiheimo J; Miinalainen I; Alen M; Kaprio J; Sipilä S; Säämänen AM; Kovanen V; Laakkonen EK
Sci Rep; 2017 Feb; 7():42702. PubMed ID: 28195143
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder.
Martinez B; Peplow PV
Neural Regen Res; 2024 Mar; 19(3):557-562. PubMed ID: 37721284
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs regulate the vicious cycle of vascular calcification-osteoporosis in postmenopausal women.
Wang Q; Peng F; Yang J; Chen X; Peng Z; Zhang M; Tang D; Liu J; Zhao H
Mol Biol Rep; 2024 May; 51(1):622. PubMed ID: 38709309
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating microRNA-21 level as a potential indicator for predicting a higher risk of incident fragility fractures.
Si ZX; Zhou SF; Shen ZL; Yan JL
J Osteopath Med; 2024 Mar; 124(3):121-125. PubMed ID: 37883102
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment.
Martinez B; Peplow PV
Neural Regen Res; 2024 Jul; 19(7):1523-1531. PubMed ID: 38051895
[TBL] [Abstract][Full Text] [Related]
18. In silico engineering and simulation of RNA interferences nanoplatforms for osteoporosis treating and bone healing promoting.
Imanpour A; Kolahi Azar H; Makarem D; Nematollahi Z; Nahavandi R; Rostami M; Beheshtizadeh N
Sci Rep; 2023 Oct; 13(1):18185. PubMed ID: 37875547
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in bone diseases.
Gennari L; Bianciardi S; Merlotti D
Osteoporos Int; 2017 Apr; 28(4):1191-1213. PubMed ID: 27904930
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
